Status:
COMPLETED
Study of Cytokines in Children With Opsoclonus-Myoclonus Syndrome
Lead Sponsor:
National Pediatric Neuroinflammation Organization, Inc.
Conditions:
Opsoclonus-myoclonus Syndrome
Eligibility:
All Genders
1-18 years
Brief Summary
The purpose of this study is to determine if cytokines, inflammatory mediators, are increased in spinal fluid and blood, correlate with disease activity, and could serve as biomarkers or therapeutic t...
Detailed Description
In this translational research, immunological mechanisms that underlie the assault of the immune system on the brain in paraneoplastic opsoclonus-myoclonus syndrome (OMS) are under evaluation. To test...
Eligibility Criteria
Inclusion
- Clinical diagnosis of OMS
Exclusion
- Equivocal diagnosis
- Contraindications to lumbar puncture
- Treatment with agents outside the scope of the study
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00806182
Start Date
January 1 2008
End Date
December 1 2016
Last Update
May 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Pediatric Myoclonus Center, Formerly at Dept. of Neurology, Southern Illinois University School of Medicine
Springfield, Illinois, United States, 62702